Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Ernexa Therapeutics Inc. Warrants logo

Ernexa Therapeutics Inc. Warrants (ERNAW) Stock Ticker

NASDAQ: ERNAW · Healthcare · Biotechnology
$0.0351+0.29%
USD · as of 2026-09-27 · market cap $275,644
Open ERNAW in TickrDownload for iPhone

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full ERNAW picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on ERNAW
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Ernexa Therapeutics Inc. Warrants

Operating in the preclinical phase, Ernexa Therapeutics Inc. is dedicated to advancing therapies based on induced mesenchymal stem cells (iMSC) to combat both solid tumors and autoimmune conditions. Its primary therapeutic, ERNA-101, is an allogeneic iMSC specifically formulated to secrete pro-inflammatory cytokines like IL-7 and IL-15 for the treatment of ovarian cancer. Complementing this, ERNA-102 is another iMSC designed to deliver the anti-inflammatory cytokine IL-10, targeting rheumatoid arthritis. Ernexa Therapeutics has secured a licensing agreement with Factor Bioscience Limited. The company, founded in 2018 and headquartered in Cambridge, Massachusetts, was formerly named Eterna Therapeutics Inc., before officially changing to Ernexa Therapeutics in March 2025.

ERNAW stock facts

Ticker symbolERNAW
ExchangeNASDAQ Capital Market
SectorHealthcare
IndustryBiotechnology
Market cap$275,644
CEOSanjeev Luther
Employees5
HeadquartersCambridge, MA, US
IPO date2024-07-12
Websitewww.ernexatx.com

What you can see for ERNAW on Tickr

Live ERNAW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ERNAW report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Ernexa Therapeutics Inc. Warrants?

The ticker symbol for Ernexa Therapeutics Inc. Warrants is ERNAW, listed on the NASDAQ Capital Market.

What is ERNAW?

Operating in the preclinical phase, Ernexa Therapeutics Inc. is dedicated to advancing therapies based on induced mesenchymal stem cells (iMSC) to combat both solid tumors and autoimmune conditions. Its primary therapeutic, ERNA-101, is an allogeneic iMSC specifically formulated to secrete pro-inflammatory cytokines like IL-7 and IL-15 for the treatment of ovarian cancer. Complementing this,…

HomeExploreMarketLists
All pages